Friday, November 20, 2026

i-SENS, Inc.'s Blood Gas Analyzer Named a Next-Generation World-Class Product

Input
2026-11-20 08:52:15
Updated
2026-11-20 08:52:15
[Financial News] The blood gas analyzer made by i-SENS, Inc., a biosensor specialist, has been selected as a 2026 Next-Generation World-Class Product, an initiative overseen by the Ministry of Trade, Industry and Energy and the Korea Trade-Investment Promotion Agency (KOTRA).
i-SENS, Inc. said on the 20th that it received the certificate at a ceremony held on the 17th at LOTTE HOTEL WORLD in Jamsil, Seoul. Oh Bong-gyun, the company's chief technology officer (CTO), attended the ceremony.
The Next-Generation World-Class Product program selects products with the potential to become a “Current World-Class Product” ranked among the top five in global market share within the next seven years. Selected companies receive preferential treatment when participating in government support programs, including overseas marketing, research and development, and financial support.
The blood gas analyzer selected this time is a point-of-care product that analyzes key indicators in a patient's blood, including oxygen, carbon dioxide and acidity, to help medical professionals make diagnostic and treatment decisions in emergencies. i-SENS, Inc. currently supplies products including the i-SmartCare 10 and i-Smart 300.
The i-SmartCare 10, the company's flagship product, directly measures up to 10 parameters within 50 seconds and provides calculated results for 13 parameters. It incorporates an all-in-one cartridge system and core sensor technology, and its cartridges can be stored at room temperature, between 15 and 25°C. Its built-in battery lasts up to two hours, and its compact design allows it to be used not only in emergency rooms and intensive care units but also in mobile settings.
Following this selection, i-SENS, Inc. plans to expand its overseas sales by making use of government support programs, including KOTRA's overseas marketing initiatives. The company plans to publicize its certification record to local buyers and medical institutions and broaden opportunities to supply its blood gas analyzers overseas.
Founded in 2000, i-SENS, Inc. develops and manufactures blood glucose monitoring systems (BGMS), continuous glucose monitoring systems (CGMS), and point-of-care testing (POCT) products, among others. It currently exports products to at least 114 countries and is expanding its product range to include blood gas, electrolyte and glycated hemoglobin analyzers.

[email protected] Jung Sang-hee Reporter